Vitamin markets remain subdued, with weak demand, modest price declines, and limited buyer engagement across regions. Ongoing uncertainty around BASF’s force majeure continues to cloud the outlook. While Q2 is largely contracted, Q3 activity is slow and cautious. (Vitamin market update week 23) Highlights: Vitamin E 50%: Prices have declined slightly across all regions. Q2 and some Q3 volumes are already contracted. BASF has not yet resumed its vitamin operations or lifted its force maje
Get full access to all stories on All About Feed
This Premium article is exclusively available for subscribers.
Obtain insights from exclusive interviews
Dive into articles covering trending industry topics
Stay up-to-date on the market trends
All the news is brought to you by experienced editors and experts from around the world
Marieke
Ploegmakers
Matthew
Wedzerai
Treena
Hein
